{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:55:42Z","timestamp":1793228142731,"version":"4.5.0"},"reference-count":149,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jacc.2022.03.337","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T13:59:24Z","timestamp":1652104764000},"page":"1932-1948","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":198,"title":["The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2536-2871","authenticated-orcid":false,"given":"A. John","family":"Camm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald V.","family":"Naccarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suneet","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry J.G.M.","family":"Crijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan H.","family":"Hohnloser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Sheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Natale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mintu P.","family":"Turakhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus","family":"Kirchhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2022.03.337_bib1","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/CIRCRESAHA.114.303211","article-title":"The clinical profile and pathophysiology of atrial fibrillation","volume":"114","author":"Andrade","year":"2014","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.jacc.2022.03.337_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.03.337_bib3","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1161\/STROKEAHA.113.001884","article-title":"Improved detection of silent atrial fibrillation using 72-hour Holter ECG in patients with ischemic stroke: a prospective multicenter cohort study","volume":"44","author":"Grond","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2022.03.337_bib4","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1161\/CIRCULATIONAHA.119.040267","article-title":"Searching for atrial fibrillation poststroke: a white paper of the AF-SCREEN International Collaboration","volume":"140","author":"Schnabel","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.03.337_bib5","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1253\/circj.CJ-17-1423","article-title":"Treatment strategies for atrial fibrillation with left ventricular systolic dysfunction: meta-analysis","volume":"82","author":"Ahn","year":"2018","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2022.03.337_bib6","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.acvd.2011.11.005","article-title":"Rate versus rhythm control in atrial fibrillation and clinical outcomes: updated systematic review and meta-analysis of randomized controlled trials","volume":"105","author":"Caldeira","year":"2012","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2022.03.337_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40266-019-00722-4","article-title":"Clinical outcomes of rate vs rhythm control for atrial fibrillation in older people: a systematic review and meta-analysis","volume":"37","author":"Depoorter","year":"2020","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jacc.2022.03.337_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186856","article-title":"The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: a systematic review with meta-analysis and trial sequential analysis","volume":"12","author":"Sethi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2022.03.337_bib9","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1253\/circj.CJ-09-0643","article-title":"Impact of drug alteration to maintain rhythm control in paroxysmal atrial fibrillation. Subanalysis from J-RHYTHM study","volume":"74","author":"Endo","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2022.03.337_bib10","doi-asserted-by":"crossref","first-page":"ii14","DOI":"10.1093\/europace\/euaa426","article-title":"Antiarrhythmic drugs for atrial fibrillation: lessons from the past and opportunities for the future","volume":"23","author":"Heijman","year":"2021","journal-title":"EP Europace"},{"key":"10.1016\/j.jacc.2022.03.337_bib11","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMoa0803778","article-title":"Effect of dronedarone on cardiovascular events in atrial fibrillation","volume":"360","author":"Hohnloser","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib12","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.jacc.2022.03.337_bib13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2029980","article-title":"Cryoablation or drug therapy for initial treatment of atrial fibrillation","volume":"384","author":"Andrade","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib14","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/europace\/euaa298","article-title":"Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST)","volume":"23","author":"Kuck","year":"2021","journal-title":"Europace"},{"issue":"21","key":"10.1016\/j.jacc.2022.03.337_bib15","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jacc.2022.03.337_bib16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"January","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib17","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(00)03230-X","article-title":"Rhythm or rate control in atrial fibrillation \u2014 Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial","volume":"356","author":"Hohnloser","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2022.03.337_bib18","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A\u00a0comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib19","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","article-title":"A\u00a0comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation","volume":"347","author":"Van Gelder","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib20","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","article-title":"Rhythm control versus rate control for atrial fibrillation and heart failure","volume":"358","author":"Roy","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib21","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/S0735-1097(03)00332-2","article-title":"Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study","volume":"41","author":"Carlsson","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib22","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1253\/circj.CJ-08-0608","article-title":"Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM study","volume":"73","author":"Ogawa","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2022.03.337_bib23","article-title":"Provider specialty and atrial fibrillation treatment strategies in United States community practice: findings from the ORBIT-AF registry","volume":"2","author":"Fosbol","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2022.03.337_bib24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/europace\/eut263","article-title":"Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC guidelines on atrial fibrillation: primary results of the Prevention of Thromboemolic Events\u2013European Registry in Atrial Fibrillation (PREFER in AF)","volume":"16","author":"Kirchhof","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2022.03.337_bib25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/eurheartj\/ehi637","article-title":"Mending the rhythm does not improve prognosis in patients with persistent atrial fibrillation: a subanalysis of the RACE study","volume":"27","author":"Rienstra","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.03.337_bib26","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/eurheartj\/ehx739","article-title":"Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial","volume":"39","author":"Rienstra","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.03.337_bib27","article-title":"Long-term outcome of targeted therapy of underlying conditions in patients with early persistent atrial fibrillation and heart failure: data of the RACE 3 trial","author":"Nguyen","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2022.03.337_bib28","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.ahj.2004.11.030","article-title":"Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: results from the RAte Control Versus Electrical Cardioversion (RACE) study","volume":"149","author":"Hagens","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2022.03.337_bib29","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jacc.2005.05.078","article-title":"Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study","volume":"46","author":"Rienstra","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib30","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/eurheartj\/ehl436","article-title":"Enhanced cardiovascular morbidity and mortality during rhythm control treatment in persistent atrial fibrillation in hypertensives: data of the RACE study","volume":"28","author":"Rienstra","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.03.337_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2019.10.005","article-title":"Impact of initial heart failure emergence on clinical outcomes of atrial fibrillation patients in the AFFIRM trial","volume":"220","author":"Slee","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2022.03.337_bib32","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/01.CIR.0000121736.16643.11","article-title":"Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study","volume":"109","author":"Corley","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.03.337_bib33","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.hrthm.2004.07.007","article-title":"Alternative endpoints for mortality in studies of patients with atrial fibrillation: the AFFIRM study experience","volume":"1","author":"Wyse","year":"2004","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2022.03.337_bib34","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/archinte.165.10.1185","article-title":"Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study","volume":"165","author":"Sherman","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib35","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ahj.2004.11.015","article-title":"Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study","volume":"149","author":"DiMarco","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2022.03.337_bib36","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0735-1097(00)00886-X","article-title":"The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy","volume":"36","author":"Dorian","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib37","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.amjmed.2005.10.057","article-title":"Quality of life in patients with atrial fibrillation: a systematic review","volume":"119","author":"Thrall","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib38","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/euhj.2001.2180","article-title":"Quality of life in patients with paroxysmal atrial fibrillation and its predictors: importance of the autonomic nervous system","volume":"22","author":"van den Berg","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.03.337_bib39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jacc.2003.08.037","article-title":"Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study","volume":"43","author":"Hagens","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib40","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/S0195-668X(03)00261-6","article-title":"Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study","volume":"24","author":"Gr\u00f6nefeld","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.03.337_bib41","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/HCQ.0000000000000011","volume":"7","author":"Ha","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2022.03.337_bib42","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jama.2019.0692","article-title":"Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Mark","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jacc.2022.03.337_bib43","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00392-021-01914-y","article-title":"Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF long-term general registry","volume":"111","author":"Proietti","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib44","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.2019.0335","article-title":"Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial","volume":"321","author":"Blomstr\u00f6m-Lundqvist","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2022.03.337_bib45","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jama.2009.2029","article-title":"Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial","volume":"303","author":"Wilber","year":"2010","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.jacc.2022.03.337_bib46","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1001\/jamacardio.2021.3063","article-title":"Association of atrial fibrillation burden with health-related quality of life after atrial fibrillation ablation: substudy of the Cryoballoon vs Contact-Force Atrial Fibrillation Ablation (CIRCA-DOSE) randomized clinical trial","volume":"6","author":"Samuel","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib47","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","article-title":"Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device","volume":"133","author":"Biase","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.03.337_bib48","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/heartjnl-2020-318676","article-title":"Quality of life and healthcare utilisation improvements after atrial fibrillation ablation","volume":"107","author":"Gupta","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2022.03.337_bib49","doi-asserted-by":"crossref","first-page":"581837","DOI":"10.3389\/fphar.2020.581837","article-title":"Revisiting antiarrhythmic drug therapy for atrial fibrillation: reviewing lessons learned and redefining therapeutic paradigms","volume":"11","author":"Geng","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jacc.2022.03.337_bib50","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(12)60570-4","article-title":"Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial","volume":"380","author":"Kirchhof","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2022.03.337_bib51","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1056\/NEJMoa041233","article-title":"Outpatient treatment of recent-onset atrial fibrillation with the \u201cpill-in-the-pocket\u201d approach","volume":"351","author":"Alboni","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib52","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM200003303421302","article-title":"Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators","volume":"342","author":"Roy","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib53","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJMoa041705","article-title":"Amiodarone versus sotalol for atrial fibrillation","volume":"352","author":"Singh","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib54","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM200003303421302","article-title":"Amiodarone to prevent recurrence of atrial fibrillation","volume":"342","author":"Roy","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib55","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/CIRCULATIONAHA.111.019927","article-title":"Antiarrhythmic drug therapy for atrial fibrillation","volume":"125","author":"Zimetbaum","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.03.337_bib56","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.03.034","article-title":"Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation: RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation)","volume":"58","author":"Camm","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib57","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archinte.165.3.258","article-title":"Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis","volume":"165","author":"de Denus","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib58","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1093\/eurheartj\/ehi306","article-title":"Rate-control vs. rhythm-control in patients with atrial fibrillation: a meta-analysis","volume":"26","author":"Testa","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.03.337_bib59","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2125.2005.02449.x","article-title":"Rhythm vs rate control of atrial fibrillation meta-analysed by number needed to treat","volume":"60","author":"Kumana","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2022.03.337_bib60","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/01.CIR.0000118472.77237.FA","article-title":"Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study","volume":"109","author":"Steinberg","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.03.337_bib61","article-title":"Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation","volume":"9","author":"Valembois","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2022.03.337_bib62","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/archinternmed.2012.2266","article-title":"Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation","volume":"172","author":"Ionescu-Ittu","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib63","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial","volume":"324","author":"Echt","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib64","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJM199207233270403","article-title":"Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction","volume":"327","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib65","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0002-9149(99)80717-6","article-title":"Survival with oral d-sotalol in patients with left ventricular dysfunction after myocardial infarction: rationale, design, and methods (the SWORD trial)","volume":"75","author":"Waldo","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib66","doi-asserted-by":"crossref","first-page":"35d","DOI":"10.1016\/S0002-9149(98)00151-9","article-title":"The Azimilide Post-Infarct Survival Evaluation (ALIVE) trial","volume":"81","author":"Camm","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib67","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2022.03.337_bib68","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/heartjnl-2016-309781","article-title":"Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial","volume":"103","author":"Cosedis Nielsen","year":"2017","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.jacc.2022.03.337_bib69","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jacc.2021.04.080","article-title":"Do mineralocorticoid receptor antagonists suppress atrial fibrillation\/flutter?","volume":"78","author":"Naccarelli","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib70","doi-asserted-by":"crossref","first-page":"d1250","DOI":"10.1136\/bmj.d1250","article-title":"Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials","volume":"342","author":"Rahimi","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2022.03.337_bib71","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jacc.2007.09.063","article-title":"Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials","volume":"51","author":"Fauchier","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib72","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1471-2261-14-99","article-title":"The preventive effect of atorvastatin on atrial fibrillation: a meta-analysis of randomized controlled trials","volume":"14","author":"Yang","year":"2014","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacc.2022.03.337_bib73","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12933-014-0123-x","article-title":"Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in\u00a0vitro studies","volume":"13","author":"Chang","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacc.2022.03.337_bib74","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12872-017-0531-4","article-title":"Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysis","volume":"17","author":"Zhang","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacc.2022.03.337_bib75","article-title":"Effects of mineralocorticoid receptor antagonists on atrial fibrillation occurrence: a systematic review, meta-analysis, and meta-regression to identify modifying factors","volume":"8","author":"Alexandre","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2022.03.337_bib76","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/europace\/eur002","article-title":"Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention","volume":"13","author":"Savelieva","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2022.03.337_bib77","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12933-021-01293-8","article-title":"Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis","volume":"20","author":"Li","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacc.2022.03.337_bib78","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa054686","article-title":"Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter","volume":"357","author":"Singh","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib79","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1540-8167.2010.01764.x","article-title":"A\u00a0short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study","volume":"21","author":"Le Heuzey","year":"2010","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib80","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/CIRCEP.108.824789","article-title":"Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation","volume":"2","author":"Calkins","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib81","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/europace\/eux275","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary","volume":"20","author":"Calkins","year":"2018","journal-title":"Europace"},{"issue":"3","key":"10.1016\/j.jacc.2022.03.337_bib82","first-page":"284","article-title":"Life-threatening complications of atrial fibrillation ablation","volume":"5","author":"Rehman","year":"2019","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2022.03.337_bib83","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1056\/NEJMoa1113566","article-title":"Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation","volume":"367","author":"Cosedis Nielsen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.jacc.2022.03.337_bib84","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2029554","article-title":"Cryoballoon ablation as initial therapy for atrial fibrillation","volume":"384","author":"Wazni","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib85","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/europace\/euab029","article-title":"Cryoballoon ablation vs antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation","volume":"23","author":"Kuniss","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2022.03.337_bib86","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1540-8167.2008.01275.x","article-title":"Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy","volume":"20","author":"Forleo","year":"2009","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib87","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1161\/CIRCULATIONAHA.108.772582","article-title":"Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study","volume":"118","author":"Ja\u00efs","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.03.337_bib88","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1056\/NEJMoa050955","article-title":"Circumferential pulmonary-vein ablation for chronic atrial fibrillation","volume":"354","author":"Oral","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib89","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.jacc.2012.11.064","article-title":"Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial","volume":"61","author":"Packer","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib90","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.jacc.2006.08.037","article-title":"A\u00a0randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF study","volume":"48","author":"Pappone","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib91","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/eurheartj\/ehi583","article-title":"Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation for the Cure of Atrial Fibrillation study)","volume":"27","author":"Stabile","year":"2006","journal-title":"Eur Heart J"},{"issue":"suppl 1","key":"10.1016\/j.jacc.2022.03.337_bib92","first-page":"S8","article-title":"A\u00a0randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation","volume":"86","author":"Krittayaphong","year":"2003","journal-title":"J\u00a0Med Assoc Thai"},{"key":"10.1016\/j.jacc.2022.03.337_bib93","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/jama.2014.467","article-title":"Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2): a randomized trial","volume":"311","author":"Morillo","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2022.03.337_bib94","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1001\/jama.293.21.2634","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial","volume":"293","author":"Wazni","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2022.03.337_bib95","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1016\/j.jacc.2020.04.065","article-title":"Recurrence of atrial fibrillation after catheter ablation or antiarrhythmic drug therapy in the CABANA trial","volume":"75","author":"Poole","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib96","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1161\/CIRCULATIONAHA.120.050991","article-title":"Ablation versus drug therapy for atrial fibrillation in heart failure","volume":"143","author":"Packer","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.03.337_bib97","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7326\/M18-0992","article-title":"Catheter ablation of atrial fibrillation in patients with heart failure: a meta-analysis of randomized controlled trials","volume":"170","author":"Turagam","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib98","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMoa041018","article-title":"Catheter ablation for atrial fibrillation in congestive heart failure","volume":"351","author":"Hsu","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib99","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib100","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/CIRCULATIONAHA.118.034583","article-title":"Building castles in the sky","volume":"138","author":"Packer","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.03.337_bib101","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1093\/eurheartj\/ehz782","article-title":"Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation","volume":"40","author":"Willems","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.03.337_bib102","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijcard.2018.03.068","article-title":"Association of catheter ablation for atrial fibrillation with mortality and stroke: a systematic review and meta-analysis","volume":"266","author":"Barra","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib103","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/jce.14429","article-title":"Impact of atrial fibrillation catheter ablation on mortality, stroke, and heart failure hospitalizations: a meta-analysis","volume":"31","author":"Saglietto","year":"2020","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib104","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1161\/CIRCULATIONAHA.109.875252","volume":"120","author":"Connolly","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.03.337_bib105","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/clc.23309","article-title":"Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation\/flutter: insights from the ATHENA study","volume":"43","author":"Vamos","year":"2020","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib106","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/europace\/eur102","article-title":"Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study","volume":"13","author":"Torp-Pedersen","year":"2011","journal-title":"EP Europace"},{"key":"10.1016\/j.jacc.2022.03.337_bib107","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.amjcard.2020.08.026","article-title":"Outcomes associated with dronedarone use in patients with atrial fibrillation","volume":"135","author":"Goehring","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib108","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ahj.2018.06.018","article-title":"Ventricular arrhythmia and death among atrial fibrillation patients using anti-arrhythmic drugs","volume":"205","author":"Friberg","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2022.03.337_bib109","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/europace\/eut293","article-title":"Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trial","volume":"16","author":"Pisters","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2022.03.337_bib110","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1056\/NEJMoa0800456","article-title":"Increased mortality after dronedarone therapy for severe heart failure","volume":"358","author":"K\u00f8ber","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib111","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMoa1109867","article-title":"Dronedarone in high-risk permanent atrial fibrillation","volume":"365","author":"Connolly","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib112","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/clc.23463","article-title":"Efficacy and safety of dronedarone by atrial fibrillation history duration: Insights from the ATHENA study","volume":"43","author":"Blomstr\u00f6m-Lundqvist","year":"2020","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib113","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/europace\/eum276","article-title":"Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode","volume":"10","author":"Cosio","year":"2008","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2022.03.337_bib114","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1152\/physrev.00031.2009","article-title":"Pathophysiological mechanisms of atrial fibrillation: a translational appraisal","volume":"91","author":"Schotten","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jacc.2022.03.337_bib115","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/eurheartj\/ehu028","article-title":"Early management of atrial fibrillation to prevent cardiovascular complications","volume":"35","author":"Nattel","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.03.337_bib116","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1741-7015-7-72","article-title":"Can we improve outcomes in AF patients by early therapy?","volume":"7","author":"Kirchhof","year":"2009","journal-title":"BMC Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib117","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.amjcard.2010.11.028","article-title":"Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial)","volume":"107","author":"Page","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib118","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ahj.2013.05.015","article-title":"Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial Fibrillation for Stroke Prevention trial","volume":"166","author":"Kirchhof","year":"2013","journal-title":"Am Heart J"},{"issue":"11","key":"10.1016\/j.jacc.2022.03.337_bib119","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.121.056323","article-title":"Early rhythm control therapy in patients with atrial fibrillation and heart failure","volume":"144","author":"Rillig","year":"2021","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.jacc.2022.03.337_bib120","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/eurheartj\/ehab593","article-title":"Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial","volume":"43","author":"Willems","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.03.337_bib121","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.03.337_bib122","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.hrthm.2020.12.025","article-title":"The role of timing in treatment of atrial fibrillation: an AFFIRM substudy","volume":"18","author":"Yang","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2022.03.337_bib123","doi-asserted-by":"crossref","first-page":"n991","DOI":"10.1136\/bmj.n991","article-title":"Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study","volume":"373","author":"Kim","year":"2021","journal-title":"BMJ"},{"issue":"suppl 1","key":"10.1016\/j.jacc.2022.03.337_bib124","article-title":"Generalizability of the EAST-AFNET 4 trial: assessing outcomes of early rhythm-control therapy in patients with atrial fibrillation","volume":"42","author":"Dickow","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.03.337_bib125","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab724.0587","article-title":"Early rhythm-control therapy in patients with atrial fibrillation: a nationwide cohort study","volume":"42","author":"Chao","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.03.337_bib126","article-title":"Comparative effectiveness of early rhythm control versus rate control for cardiovascular outcomes in patients with atrial fibrillation","volume":"10","author":"Kim","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2022.03.337_bib127","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1161\/CIRCULATIONAHA.107.723866","article-title":"Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial","volume":"117","author":"Roy","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.03.337_bib128","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJM199906173402401","article-title":"Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment","volume":"340","author":"Oral","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib129","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.008128","article-title":"Diagnosis-to-ablation time and recurrence of atrial fibrillation following catheter ablation: a systematic review and meta-analysis of observational studies","volume":"13","author":"Chew","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib130","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.008461","article-title":"Impact of left ventricular function and heart failure symptoms on outcomes post ablation of atrial fibrillation in heart failure: CASTLE-AF Trial","volume":"13","author":"Sohns","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib131","first-page":"100898","article-title":"Small conductance calcium activated K(+) channel inhibitor decreases stretch induced vulnerability to atrial fibrillation","volume":"37","author":"Yan","year":"2021","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.jacc.2022.03.337_bib132","article-title":"Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy","author":"Wiedmann","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2022.03.337_bib133","doi-asserted-by":"crossref","DOI":"10.3390\/diseases9020031","article-title":"Role of ranolazine in the prevention and treatment of atrial fibrillation in patients with left ventricular systolic dysfunction: a meta-analysis of randomized clinical trials","volume":"9","author":"Leelapatana","year":"2021","journal-title":"Diseases"},{"key":"10.1016\/j.jacc.2022.03.337_bib134","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejphar.2018.12.009","article-title":"Characteristics of hERG and hNav1.5 channel blockade by sulcardine sulfate, a novel anti-arrhythmic compound","volume":"844","author":"Chen","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jacc.2022.03.337_bib135","first-page":"614","article-title":"Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of IMPULSE, PEFCAT, and PEFCAT II","volume":"7","author":"Reddy","year":"2021","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2022.03.337_bib136","first-page":"10","article-title":"Ablation modalities for therapeutic intervention in arrhythmia-related cardiovascular disease: focus on electroporation","author":"McBride","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib137","article-title":"Robotic-assisted biatrial Cox-maze ablation for atrial fibrillation","author":"Badhwar","year":"2021","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2022.03.337_bib138","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/CIRCRESAHA.119.316342","article-title":"Emerging technologies for identifying atrial fibrillation","volume":"127","author":"Ding","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2022.03.337_bib139","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002903","article-title":"Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals","volume":"16","author":"Lowres","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib140","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jamacardio.2018.0136","article-title":"Passive detection of atrial fibrillation using a commercially available smartwatch","volume":"3","author":"Tison","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2022.03.337_bib141","first-page":"199","article-title":"The WATCH AF trial: SmartWATCHes for detection of atrial fibrillation","volume":"5","author":"D\u00f6rr","year":"2019","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2022.03.337_bib142","doi-asserted-by":"crossref","DOI":"10.2196\/29225","article-title":"Machine learning methodologies for prediction of rhythm-control strategy in patients diagnosed with atrial fibrillation: observational, retrospective, case-control study","volume":"9","author":"Kim","year":"2021","journal-title":"JMIR Med Inform"},{"key":"10.1016\/j.jacc.2022.03.337_bib143","article-title":"Rhythm- or rate-control strategies according to 4S-AF characterization scheme and long-term outcomes in atrial fibrillation patients: the FAMo (Fibrillazione Atriale in Modena) cohort","author":"Malavasi","year":"2021","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.jacc.2022.03.337_bib144","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16173042","article-title":"Health-related quality of life and associated factors in patients with atrial fibrillation: an integrative literature review","volume":"16","author":"Son","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jacc.2022.03.337_bib146","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1016\/j.hrthm.2017.07.009","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2022.03.337_bib147","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1023\/A:1027499114087","article-title":"Confounding factors in rate versus rhythm control trials in patients with atrial fibrillation: lessons from the strategies of treatment of atrial fibrillation (STAF) pilot study","volume":"7","author":"Carlsson","year":"2003","journal-title":"Card Electrophysiol Rev"},{"key":"10.1016\/j.jacc.2022.03.337_bib148","first-page":"931","article-title":"The Japanese Guidelines for Atrial Fibrillation Management. [In Japanese","volume":"65","year":"2001","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.jacc.2022.03.337_bib149","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.03.337_bib150","first-page":"e1","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"50","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109722044886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109722044886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:49:23Z","timestamp":1760017763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109722044886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":149,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0735109722044886"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2022.03.337","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2022.03.337","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}